Related Experiment Video
Updated: Aug 16, 2025

09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
14.6K
Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy
Kyeong Jin Cho1, Young-Eun Cho2, Jihoon Kim1
1Division of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.
Pharmaceutics
|December 23, 2022
Summary
This study explores using nano-sized materials and sustained drug delivery systems to target the lymphatic system for enhanced cancer immunotherapy. These advanced formulations aim to boost the immune response against tumors.
Area of Science:
- Immunology
- Nanotechnology
- Drug Delivery
Background:
- The lymphatic system is crucial for adaptive immunity and cancer progression.
- Nano-sized materials show promise for drug transport to lymph nodes, overcoming physiological barriers.
- Sustained drug delivery systems are being investigated for improved immune modulation therapies.
Purpose of the Study:
- To discuss design principles for locoregional lymphatic drug delivery systems.
- To explore invigorating adaptive immune response for effective antitumor immunotherapy.
- To present examples of nanoparticle- and hydrogel-based formulations for lymphatic drug delivery.
Main Methods:
- Review of mechanistic studies on nano-sized materials in lymphatic transport.
- Discussion of design rationales for sustained drug delivery systems.
- Analysis of nanoparticle- and hydrogel-based formulations for immunotherapy.
Main Results:
- Nano-sized materials facilitate cargo transport to lymph nodes.
- Sustained delivery systems can improve the therapeutic index of immune modulators.
- Locoregional lymphatic drug delivery offers a strategy for enhancing antitumor immunotherapy.
Conclusions:
- Advanced nanoparticle and hydrogel formulations are promising for lymphatic drug delivery.
- Targeting the lymphatic system with these systems can invigorate adaptive immunity.
- This approach holds potential for developing more efficient antitumor immunotherapies.

